Search results for "Bioinformatics"

showing 10 items of 1632 documents

catena-Poly[[(18-crown-6-κ6O)potassium]-μ-chlorido-[(1H-benzotriazol-1-ol-κN3)chloridoplatinum(II)]-μ-(benzotriazol-1-olato-κ2N3:O)]

2010

In the structure of the title compound, [KPt(C6H4N3O)Cl2(C6H5N3O)(C12H24O6)], the PtII atom is in a distorted square-planar geometry. The crystal structure is consolidated by O—H⋯O hydrogen bonds. The measured crystal was a non-merohedral twin with four components.

1H-BenzotriazolHydrogen bondPotassium18-Crown-6chemistry.chemical_elementGeneral ChemistryCrystal structureCondensed Matter PhysicsBioinformaticsCrystalchemistry.chemical_compoundCrystallographychemistryGeneral Materials ScienceActa Crystallographica Section E Structure Reports Online
researchProduct

Metabolic Syndrome: From Molecular Mechanisms to Novel Therapies

2021

The metabolic syndrome (MetS) consists of a cluster of metabolic abnormalities including central obesity, insulin resistance, glucose intolerance, hypertension, and atherogenic dyslipidemia [...]

2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)QH301-705.5Disease clusterBioinformaticsCatalysisInorganic ChemistryInsulin resistanceDiabetes mellitusmedicineAnimalsHumansObesityPhysical and Theoretical ChemistryBiology (General)Molecular BiologyQD1-999SpectroscopyMetabolic SyndromeAtherogenic dyslipidemiabusiness.industryOrganic ChemistryAnimals Diabetes Mellitus Type 2 Humans Insulin Resistance Metabolic Syndrome ObesityGeneral Medicinemedicine.diseaseObesityComputer Science ApplicationsChemistryEditorialn/aDiabetes Mellitus Type 2Metabolic syndromeInsulin ResistancebusinessInternational Journal of Molecular Sciences
researchProduct

Challenges and Opportunities on Lipid Metabolism Disorders Diagnosis and Therapy: Novel Insights and Future Perspective

2021

Dyslipidemia has been globally recognized, for almost seven decades, as one of the most important risk factors for the development and complications of atherosclerotic cardiovascular disease (ASCVD) [...]

2019-20 coronavirus outbreakFuture perspectiveLipid Metabolism DisorderCoronavirus disease 2019 (COVID-19)Atherosclerotic cardiovascular diseasebusiness.industryEndocrinology Diabetes and MetabolismSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)medicine.diseaseBioinformaticsBiochemistryMicrobiologyQR1-502Editorialn/amedicinebusinessMolecular BiologyDyslipidemialipidi colesterolMetabolites
researchProduct

The Millennial Generation of Thrombosis and Hemostasis

2020

2019-20 coronavirus outbreakHemostasisCoronavirus disease 2019 (COVID-19)business.industry10031 Clinic for AngiologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2720 Hematology610 Medicine & healthThrombosisHematologyBioinformaticsmedicine.diseaseThrombosisHemostasisMedicineHumansbusinessHämostaseologie
researchProduct

Genetic and Epigenetic Factors of Takotsubo Syndrome: A Systematic Review

2021

Takotsubo syndrome (TTS), recognized as stress’s cardiomyopathy, or as left ventricular apical balloon syndrome in recent years, is a rare pathology, described for the first time by Japanese researchers in 1990. TTS is characterized by an interindividual heterogeneity in onset and progression, and by strong predominance in postmenopausal women. The clear causes of these TTS features are uncertain, given the limited understanding of this intriguing syndrome until now. However, the increasing frequency of TTS cases in recent years, and particularly correlated to the SARS-CoV-2 pandemic, leads us to the imperative necessity both of a complete knowledge of TTS pathophysiology for identifying bi…

2019-20 coronavirus outbreakTTS managementCoronavirus disease 2019 (COVID-19)DNA Copy Number VariationsQH301-705.5Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Heart VentriclesReviewBioinformaticsPolymorphism Single NucleotideCatalysisEpigenesis GeneticInorganic ChemistryGenetic Heterogeneitysystematic reviewTakotsubo CardiomyopathyMedicineHumansGenetic Predisposition to DiseaseEpigeneticsTakotsubo cardiomyopathy (TTS)Biology (General)Physical and Theoretical ChemistryMedical History TakingQD1-999Molecular BiologySpectroscopyTakotsubo syndromePostmenopausal womenbusiness.industryGenetic heterogeneitySARS-CoV-2Organic ChemistrybiomarkersCOVID-19General Medicinespecific and effective treatmentsgenetic and epigenetic factorsComputer Science ApplicationsChemistrySettore MED/03Genetic LociIdentification (biology)businessInternational Journal of Molecular Sciences
researchProduct

The Role of Vitamin D as a Biomarker in Alzheimer’s Disease

2021

Vitamin D and cognition is a popular association, which led to a remarkable body of literature data in the past 50 years. The brain can synthesize, catabolize, and receive Vitamin D, which has been proved to regulate many cellular processes in neurons and microglia. Vitamin D helps synaptic plasticity and neurotransmission in dopaminergic neural circuits and exerts anti-inflammatory and neuroprotective activities within the brain by reducing the synthesis of pro-inflammatory cytokines and the oxidative stress load. Further, Vitamin D action in the brain has been related to the clearance of amyloid plaques, which represent a feature of Alzheimer Disease (AD), by the immune cell. Based on the…

25(OH)D levelsReviewDiseaseBioinformaticsNeuroprotectionvitamin D deficiencylcsh:RC321-57103 medical and health sciences0302 clinical medicineImmune systemVitamin D and neurologyMedicineAlzheimer’s Disease030212 general & internal medicineVitamin DCognitive declinelcsh:Neurosciences. Biological psychiatry. NeuropsychiatryVitamin D deficiencybusiness.industryGeneral NeuroscienceBiomarkermedicine.diseaseBiomarker (medicine)Alzheimer's diseasebusiness030217 neurology & neurosurgeryBrain Sciences
researchProduct

Exosome levels in human body fluids: A tumor marker by themselves?

2016

Despite considerable research efforts, the finding of reliable tumor biomarkers remains challenging and unresolved. In recent years a novel diagnostic biomedical tool with high potential has been identified in extracellular nanovesicles or exosomes. They are released by the majority of the cells and contain detailed molecular information on the cell of origin including tumor hallmarks. Exosomes can be isolated from easy accessible body fluids, and most importantly, they can provide several biomarkers, with different levels of specificity. Recent clinical evidence shows that the levels of exosomes released into body fluids may themselves represent a predictive/diagnostic of tumors, discrimin…

30030301 basic medicinePharmaceutical ScienceExosomesBioinformaticsExosome03 medical and health sciencesTumor BiomarkersProstate cancer0302 clinical medicineBody FluidNeoplasmsBiomarkers TumorHumansMedicineHigh potentialTumor markerBiomarkers; Body fluids; Early diagnosis; Exosomes; Extracellular vesicles; Follow-up; Prostate cancer; Biomarkers Tumor; Body Fluids; Humans; Neoplasm Recurrence Local; Neoplasms; Exosomes; 3003Prostate cancerSettore BIO/16 - Anatomia Umanabusiness.industryFollow-upHealthy subjectsCancerBiomarkerExtracellular vesiclesEarly diagnosiEarly diagnosismedicine.diseaseMicrovesiclesBody FluidsExosomeBody fluids030104 developmental biology030220 oncology & carcinogenesisNeoplasmExtracellular vesicleNeoplasm Recurrence LocalbusinessBiomarkersHumanEuropean Journal of Pharmaceutical Sciences
researchProduct

The effect of bergamot on dyslipidemia

2016

Abstract Background Statins are the most common used lipid lowering drugs but they may cause adverse effects and despite their well-established therapeutic benefits residual cardiovascular (CV) risk remains. The use of other lipid lowering drugs and nutraceuticals alone or as add-on lipid-modifying therapy can be an option in such cases. Several studies have reported health-related properties of the Citrus fruits, among which bergamot (Citrus bergamia Risso) differs from others by particularly high content of certain compounds. Purpose This narrative review summarizes the current evidence on the effects of bergamot on lipid parameters based on studies involving animals and humans. Main evid…

3003CitrusFuture studiesBergamotPharmaceutical Science030204 cardiovascular system & hematologyBioinformatics01 natural sciences03 medical and health scienceschemistry.chemical_compound0302 clinical medicineNutraceuticalDrug DiscoverymedicineAnimalsHumansAdverse effectDyslipidemiasHypolipidemic AgentsFlavonoidsPharmacologyPlant ExtractsChemistryCholesterolMedicine (all)Drug Discovery3003 Pharmaceutical ScienceCardiovascular riskComplementary and Alternative Medicine2708 Dermatologymedicine.disease0104 chemical sciences010404 medicinal & biomolecular chemistryDyslipidemiaComplementary and alternative medicineBiochemistryLDL cholesterolCitrus bergamiaMolecular MedicineNarrative reviewLipid loweringDyslipidemiaPhytomedicine
researchProduct

Proteomic analysis of the organic matrix of the abalone Haliotis asinina calcified shell.

2010

Abstract Background The formation of the molluscan shell is regulated to a large extent by a matrix of extracellular macromolecules that are secreted by the shell forming tissue, the mantle. This so called "calcifying matrix" is a complex mixture of proteins and glycoproteins that is assembled and occluded within the mineral phase during the calcification process. While the importance of the calcifying matrix to shell formation has long been appreciated, most of its protein components remain uncharacterised. Results Recent expressed sequence tag (EST) investigations of the mantle tissue from the tropical abalone (Haliotis asinina) provide an opportunity to further characterise the proteins …

570BiologyProteomicsBioinformaticsBiochemistry03 medical and health sciencesExtracellularlcsh:QH573-671Mantle (mollusc)[SDV.IB.BIO]Life Sciences [q-bio]/Bioengineering/BiomaterialsMolecular Biology030304 developmental biologyAlaninechemistry.chemical_classification0303 health sciencesViral matrix proteinHaliotis asininalcsh:CytologyResearch030302 biochemistry & molecular biologybiology.organism_classification[ SDV.IB.BIO ] Life Sciences [q-bio]/Bioengineering/BiomaterialsBiochemistrychemistrybiology.proteinWhey Acidic ProteinGlycoprotein
researchProduct

Deciphering genomic heterogeneity and the internal composition of tumour activities through a hierarchical factorisation model

2021

Genomic heterogeneity constitutes one of the most distinctive features of cancer diseases, limiting the efficacy and availability of medical treatments. Tumorigenesis emerges as a strongly stochastic process, producing a variable landscape of genomic configurations. In this context, matrix factorisation techniques represent a suitable approach for modelling such complex patterns of variability. In this work, we present a hierarchical factorisation model conceived from a systems biology point of view. The model integrates the topology of molecular pathways, allowing to simultaneously factorise genes and pathways activity matrices. The protocol was evaluated by using simulations, showing a hi…

:Informàtica::Aplicacions de la informàtica::Bioinformàtica [Àrees temàtiques de la UPC]Matrix factorisationComputer scienceBioinformaticsGeneral MathematicsSystems biologyPopulationMatrix factorisationContext (language use)Computational biologyComputational biologyGenomic heterogeneitygenomic heterogeneityFactorizationBioinformàticaSimulació per ordinadorComputer Science (miscellaneous)QA1-939cancerVariabilityeducationEngineering (miscellaneous)Topology (chemistry)Cancereducation.field_of_studyvariabilitymatrix factorisationLimitingbioinformaticsCàncer--Aspectes genèticsGenòmicaBreast--CancerTumorigenesisMathematics
researchProduct